New mammogram technique could spot breast cancer earlier in survivors
NCT ID NCT04085510
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether contrast-enhanced mammography (CEM) finds breast cancer more accurately than standard mammography in women who have already had breast cancer. About 1,647 women ages 30-85 will get both types of mammograms to compare detection rates and false alarms. The goal is to improve surveillance without unnecessary extra tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Magee Womancare Monroeville
Monroeville, Pennsylvania, 15146, United States
-
Magee Womancare Passavant Cranberry
Cranberry Township, Pennsylvania, 16066, United States
-
Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- A simple screening program could transform cancer aftercare